226 related articles for article (PubMed ID: 20722001)
1. Liver-specific β-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis.
Yeh TH; Krauland L; Singh V; Zou B; Devaraj P; Stolz DB; Franks J; Monga SP; Sasatomi E; Behari J
Hepatology; 2010 Oct; 52(4):1410-9. PubMed ID: 20722001
[TBL] [Abstract][Full Text] [Related]
2. Protective Functions of ZO-2/Tjp2 Expressed in Hepatocytes and Cholangiocytes Against Liver Injury and Cholestasis.
Xu J; Kausalya PJ; Van Hul N; Caldez MJ; Xu S; Ong AGM; Woo WL; Mohamed Ali S; Kaldis P; Hunziker W
Gastroenterology; 2021 May; 160(6):2103-2118. PubMed ID: 33465371
[TBL] [Abstract][Full Text] [Related]
3. Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis.
Behari J; Yeh TH; Krauland L; Otruba W; Cieply B; Hauth B; Apte U; Wu T; Evans R; Monga SP
Am J Pathol; 2010 Feb; 176(2):744-53. PubMed ID: 20019186
[TBL] [Abstract][Full Text] [Related]
4. Wnt/β-Catenin Signaling Plays a Protective Role in the Mdr2 Knockout Murine Model of Cholestatic Liver Disease.
Pradhan-Sundd T; Kosar K; Saggi H; Zhang R; Vats R; Cornuet P; Green S; Singh S; Zeng G; Sundd P; Nejak-Bowen K
Hepatology; 2020 May; 71(5):1732-1749. PubMed ID: 31489648
[TBL] [Abstract][Full Text] [Related]
5. Role of farnesoid X receptor in the enhancement of canalicular bile acid output and excretion of unconjugated bile acids: a mechanism for protection against cholic acid-induced liver toxicity.
Miyata M; Tozawa A; Otsuka H; Nakamura T; Nagata K; Gonzalez FJ; Yamazoe Y
J Pharmacol Exp Ther; 2005 Feb; 312(2):759-66. PubMed ID: 15466244
[TBL] [Abstract][Full Text] [Related]
6. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
[TBL] [Abstract][Full Text] [Related]
7. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
[TBL] [Abstract][Full Text] [Related]
8. Altered expression and function of canalicular transporters during early development of cholestatic liver injury in Abcb4-deficient mice.
Cai SY; Mennone A; Soroka CJ; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(8):G670-6. PubMed ID: 24481602
[TBL] [Abstract][Full Text] [Related]
9. Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis.
Burbank MG; Burban A; Sharanek A; Weaver RJ; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2016 Nov; 44(11):1780-1793. PubMed ID: 27538918
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional alterations of hepatocytes during transient phalloidin-induced cholestasis in the rat.
Loranger A; Barriault C; Yousef IM; Tuchweber B
Toxicol Appl Pharmacol; 1996 Mar; 137(1):100-11. PubMed ID: 8607135
[TBL] [Abstract][Full Text] [Related]
11. Metabolic preconditioning protects BSEP/ABCB11
Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
[TBL] [Abstract][Full Text] [Related]
12. Dual catenin loss in murine liver causes tight junctional deregulation and progressive intrahepatic cholestasis.
Pradhan-Sundd T; Zhou L; Vats R; Jiang A; Molina L; Singh S; Poddar M; Russell J; Stolz DB; Oertel M; Apte U; Watkins S; Ranganathan S; Nejak-Bowen KN; Sundd P; Monga SP
Hepatology; 2018 Jun; 67(6):2320-2337. PubMed ID: 29023813
[TBL] [Abstract][Full Text] [Related]
13. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis.
Wang R; Salem M; Yousef IM; Tuchweber B; Lam P; Childs SJ; Helgason CD; Ackerley C; Phillips MJ; Ling V
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):2011-6. PubMed ID: 11172067
[TBL] [Abstract][Full Text] [Related]
14. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport.
Paulusma CC; Groen A; Kunne C; Ho-Mok KS; Spijkerboer AL; Rudi de Waart D; Hoek FJ; Vreeling H; Hoeben KA; van Marle J; Pawlikowska L; Bull LN; Hofmann AF; Knisely AS; Oude Elferink RP
Hepatology; 2006 Jul; 44(1):195-204. PubMed ID: 16799980
[TBL] [Abstract][Full Text] [Related]
15. Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile.
Kurbegov AC; Setchell KD; Haas JE; Mierau GW; Narkewicz M; Bancroft JD; Karrer F; Sokol RJ
Gastroenterology; 2003 Oct; 125(4):1227-34. PubMed ID: 14517804
[TBL] [Abstract][Full Text] [Related]
16. Yinchen decoction protects against cholic acid diet-induced cholestatic liver injury in mice through liver and ileal FXR signaling.
Song G; Zou B; Zhao J; Weng F; Li Y; Xu X; Zhang S; Yan D; Jin J; Sun X; Liu C; Qiu F
J Ethnopharmacol; 2023 Sep; 313():116560. PubMed ID: 37149065
[TBL] [Abstract][Full Text] [Related]
17. Bile acid pool dynamics in progressive familial intrahepatic cholestasis with partial external bile diversion.
Jericho HS; Kaurs E; Boverhof R; Knisely A; Shneider BL; Verkade HJ; Whitington PF
J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):368-74. PubMed ID: 25383786
[TBL] [Abstract][Full Text] [Related]
18. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous repopulation of β-catenin null livers with β-catenin-positive hepatocytes after chronic murine liver injury.
Thompson MD; Wickline ED; Bowen WB; Lu A; Singh S; Misse A; Monga SP
Hepatology; 2011 Oct; 54(4):1333-43. PubMed ID: 21721031
[TBL] [Abstract][Full Text] [Related]
20. Genetic cholestasis, causes and consequences for hepatobiliary transport.
Jansen PL; Sturm E
Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
